| NOVARTIS N | 89.14 / -0.30% |
| Date/Time | 06/17 / 10:23 |
| Chg. / Chg.(%) | -0.27 / -0.30% |
| Bid | 89.13 / 14 |
| Ask | 89.14 / 981 |
| Open | 89.50 |
| Previous Close | 89.41 |
| High | 89.65 |
| Low | 89.03 |
| Volume [CHF] | 33,444,198.28 |
| Volume [Units] | 441,571 |
| Price fixings | 1725 |
| ISIN | CH0012005267 |
| Security | NOVN |
| Exchange | SIX Swiss Exchange |
| Type | Stock |
| Exchange | Last | Volume | |
|---|---|---|---|
| SIX Swiss Ex.. | 89.14 |  |
441,571 |
| Cboe Europe .. | 89.13 | |
70,608 |
| Cboe Europe .. | 89.14 | |
40,554 |
| Turquoise | 89.14 | |
17,161 |
| London Inter.. | 89.08 | |
8,705 |
| TradeGate | 79.650 | |
2,514 |
| Xetra | 79.59 | |
1,847 |
| Frankfurt | 79.570 | |
732 |
| gettex | 79.540 | |
250 |
| München | 80.35 | |
112 |
| Cboe Europe .. | 79.59 | |
25 |
| Stuttgart | 79.800 | |
15 |
| Turquoise | 79.58 | |
13 |
| Cboe Europe .. | 79.61 | |
10 |
| Berlin | 79.60 | |
3 |
| Hannover | 80.04 | |
0 |
| Düsseldorf | 80.03 | |
0 |
| Hamburg | 80.04 | |
0 |
| Lang & Schwa.. | 79.570 | |
|
| Nasdaq Other.. | 89.5675 |  |
170,872 |
| Borsa Italia.. | 79.58 | 20 | |
| Borsa Italia.. | 75.00 | 36 | |
| EUREX | Options | ||
News
- Novartis continues to innovate in CML with long-term treatment-free remission results following Tasigna® use and promising combination data with investigational compound asciminib (ABL001)
06/14/2019 / 08:30 - GlobeNewswire - Cosentyx® provides long-lasting inhibition of radiographic progression in psoriatic arthritis, new Novartis data show
06/12/2019 / 07:20 - GlobeNewswire - Novartis Cosentyx® first to show efficacy in all key manifestations of psoriatic arthritis
06/12/2019 / 07:15 - GlobeNewswire - Novartis names new pharma unit head
06/07/2019 / 07:41 - TeleTrader - Novartis announces new leader of Pharmaceuticals Business Unit
06/07/2019 / 07:00 - GlobeNewswire
Real-time